The Tax Rule Distorting an Entire Industry
When Kim Rivers helped push forward momentum behind federal cannabis reform alongside figures like Donald Trumpmost of the attention focused on politics.
But the more consequential shift is not political. It’s financial. If cannabis is reclassified under US law, one specific constraint disappears—and with it, the entire way the industry has been understood for the past decade.
At the center of that shift is Section 280E of the US tax code, a rule originally designed to prevent illegal drug traffickers from deducting business expenses. Because cannabis remains federally classified alongside those substances, legal operators are treated the same way. The result is not simply higher taxes. It is a structural distortion that reshapes how profit is calculated, reported, and ultimately perceived.
This is where the standard narrative around cannabis companies begins to break down. The assumption most investors make is straightforward: if a business consistently reports losses, something in the model is not working. Costs are too high, margins are too thin, or the market has not matured. That logic works in almost every industry. It doesn’t work here. Companies such as Trulieve generate over a billion dollars in annual revenue, operate at scale across multiple states, and dominate regional markets. Yet their financial statements suggest weakness. The instinct is to treat that as evidence of failure. In reality, it is evidence of constraint.
The mechanism is simple, but its implications are not. Under normal tax rules, businesses deduct operating expenses—salaries, rent, marketing, logistics—before calculating taxable income. Under 280E, most of those deductions disappear. Only direct production costs remain. Everything else is effectively taxed as if it were profit. The outcome is a version of taxable income that bears little resemblance to economic reality, pushing effective tax rates to levels that would be unsustainable in most industries.
Once that distortion is understood, the financial profile of the cannabis industry starts to look fundamentally different. What appears to be weak profitability is often a function of how profit is measured, not how the business performs. A company can operate efficiently, generate strong revenue, and still report losses because the majority of its cost base is not recognized. This is not a marginal effect. It is the defining feature of the sector.
How 280E Changes Behavior, Strategy, and Perception
The impact of that distortion extends far beyond financial reporting. It reshapes how companies behave. When operating expenses cannot be deducted, they become disproportionately expensive. Hiring staff, building brand, expanding locations—these are no longer neutral growth decisions. They actively increase tax exposure. The rational response is to shift as much cost as possible into areas that remain deductible, particularly cost of goods sold.
That shift introduces a subtle but important change in how businesses are run. Strategy becomes influenced by classification rather than efficiency. Decisions that would normally drive long-term value are delayed, reduced, or restructured. The industry begins to look inefficient—not because it lacks discipline, but because it is forced to operate within a framework that penalises normal behavior.
This creates a second-order effect that is easy to miss. Companies are not just adapting to the rules—they are being shaped by them. Over time, operational models evolve around tax constraints, not market optimization. The result is a sector where reported inefficiency is often mistaken for structural weakness, when in reality it is a response to external pressure.
The distortion becomes more powerful when it reaches the market. Investors rely on financial statements as signals. Revenue growth suggests demand. Profitability suggests sustainability. When one of those signals is persistently negative, it shapes perception. Cannabis has been caught in this loop for years. Strong top-line growth paired with weak earnings has led to a narrative of fragility. That narrative has influenced valuations, capital allocation, and investor appetite.
The problem is not just that the signal is negative. It is that the signal is misleading. Financial statements are technically correct, but they do not reflect the underlying economics of the business. This creates a disconnect between what companies are doing and how they are valued. That disconnect has persisted because the constraint causing it has remained in place.
Trulieve CEO Kim Rivers has built a billion-dollar cannabis business under Section 280E, where reported profits often fail to reflect underlying performance
The Mispricing Opportunity No One Completely Sees
What makes this dynamic different is not just that cannabis companies appear unprofitable, but that the gap between reported performance and underlying economics has been visible for years without being fully acted on. That creates a specific kind of inefficiency. It is not hidden information. It is misinterpreted information. The data is available, but the framework used to interpret it produces the wrong conclusion.
In most markets, inefficiencies close as information spreads. Here, the inefficiency persists because the constraint is structural. As long as Section 280E applies, financial statements continue to present a distorted view of profitability, and investors who rely on those statements at face value continue to price the sector accordingly. The result is a prolonged disconnect between how these businesses actually perform and how they are valued.
The opportunity sits in the timing of that disconnect. The moment the constraint is removed—through reclassification or a shift in enforcement—the financial picture does not gradually improve. It snaps into alignment. Expenses that were previously ignored are recognized, taxable income falls, and profitability appears almost immediately. That creates a narrow window where the underlying economics have already improved, but the market has not yet fully adjusted.
This is where the advantage becomes practical. Investors who understand the mechanism are not waiting for companies to become profitable; they are anticipating when profitability will become visible. That shifts the decision entirely. The focus moves from operational execution to regulatory timing. The question is no longer whether these businesses can generate profit, but when the system will allow that profit to be reflected in their accounts.
The same dynamic applies to operators. Companies that have built scale and survived under 280E constraints are not starting from scratch when the framework changes. They are already built. When the constraint lifts, they simply begin operating under normal conditions. That creates a divergence between companies that have used the constraint to build resilience and those that have relied on more fragile strategies to survive it.
There is also a broader effect on capital. Because reported earnings have been suppressed, many investors have treated cannabis as a speculative sector rather than a structurally constrained one. That has limited institutional participation and kept valuations lower than underlying performance might justify. When profitability becomes visible, that perception shifts. The re-rating is not just about earnings—it is about who is willing to invest.
This creates a layered adjustment. Early participants position based on understanding the distortion. The next wave reacts to visible profitability as financial statements change. A third wave follows as institutional capital enters once the sector fits within more conventional investment frameworks. Each stage is driven by the same underlying shift, but the pricing adjusts in phases.
The risk lies in the timing. If the regulatory shift is delayed or incomplete, the expected correction does not arrive in full. Companies positioned for a post-280E environment may carry costs that assume deductions they still cannot take. Investors who have priced in a rapid shift may need to reassess. The same mechanism that creates opportunity also creates exposure.
What makes this unusual is that the underlying businesses are not the variable. In most industries, valuation changes are driven by improvements in execution or demand. Here, those elements are already in place. The variable is the framework applied to them. When that framework changes, the market is forced to reassess everything it thought it understood.
What Happens When Profitability Becomes Visible
This is why Section 280E has had such an outsized influence. It has not just reduced profitability—it has delayed its visibility. That delay has shaped behavior, distorted strategy, and influenced how the entire sector is perceived. When that delay ends, the adjustment is not incremental. It is a release of something that has been building under constraint for years.
The broader lesson extends beyond cannabis. Profit is not simply the result of what a business does. It is also the result of how that business is measured. When the measurement changes, the outcome changes with it. In this case, the businesses have not fundamentally changed. The system around them has.
For those watching closely, the implication is straightforward but easy to miss. The question is not whether cannabis companies can become profitable. Many are already in economic terms. The question is when that profitability becomes impossible for the market to ignore.
